Moderna
MRNA
#1326
Rank
$13.50 B
Marketcap
$35.01
Share price
3.70%
Change (1 day)
-68.30%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

P/S ratio for Moderna (MRNA)

P/S ratio as of March 2025 (TTM): 2.67

According to Moderna 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.24. At the end of 2024 the company had a P/S ratio of 5.00.

P/S ratio history for Moderna from 2018 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.00-10.96%
20235.6153.56%
20223.66-37.03%
20215.81-96.15%
20201519.95%
2019137235.08%
201840.9

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
3.73 39.72%๐Ÿ‡บ๐Ÿ‡ธ USA
10.4 289.85%๐Ÿ‡บ๐Ÿ‡ธ USA
14.0 422.52%๐Ÿ‡บ๐Ÿ‡ธ USA
4.15 55.29%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
866 32,322.85%๐Ÿ‡บ๐Ÿ‡ธ USA
4.41 65.23%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA